Back to search
FDAFDA · Food and drugs·Recall number Z-0088-2013

Grafton DBM Matrix PLF Multiple Sizes Grafton is a human bone allograft product containing demineralized human bone tissue combined with inert additive to yield a demineralized bone matrix (DBM) allograft. It is intended for use as a bone graft extender, bone graft substitute and bone void filler in bony voids or gaps of the skeletal system (ie spine, pelvis and extremeties) not intrinsic to the stability of the bony structure. The voids or gaps may be surgically created defects or effects created by traumatic injury to the bone.

Published October 24, 2012 · Recall initiated: April 20, 2012

Summary

FDA records medical device Class II recall Z-0088-2013, published October 24, 2012 and initiated April 20, 2012. Recalling firm: Osteotech Inc; Status: Terminated; Reported quantity: 6,982 units; Lot: Multiple Lots - please see attachment. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Multiple lots of GRAFTON ¿ and XPANSE ¿, which are used for bone grafting procedures are being recalled because there is a possibility that sterility of the outer surface of the inner pouch may become compromised.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Osteotech Inc
Distributor
Worldwide Distribution - USA (nationwide) and Internationally.
Lot
Multiple Lots - please see attachment
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Grafton DBM Matrix PLF Multiple Sizes Grafton is a human bone allograft product containing demineralized human bone tissue combined with inert additive to yield a demineralized bone matrix (DBM) allograft. It is intended for use as a bone graft extender, bone graft substitute and bone void filler in bony voids or gaps of the skeletal system (ie spine, pelvis and extremeties) not intrinsic to the stability of the bony structure. The voids or gaps may be surgically created defects or effects created by traumatic injury to the bone. recalled?

Yes. FDA published recall Z-0088-2013 on October 24, 2012. Reported hazard: Multiple lots of GRAFTON ¿ and XPANSE ¿, which are used for bone grafting procedures are being recalled because there is a possibility that sterility of the outer surface of the inner pouch may become compromised.

What should I do if I have this product?

Voluntary: Firm initiated · Letter